The Limbic

Biologic effective in patients with chronic rhinosinusitis with nasal polyps

Mepolizumab reduces nasal polyp size and obstruction in patients with severe chronic rhinosinusitis, results from a large international study suggest. Researchers found that the anti-IL-5 biologic reduced the need for repeat nasal surgery and cut the use of systemic corticosteroids. Patients...

Mepolizumab reduces nasal polyp size and obstruction in patients with severe chronic rhinosinusitis, results from a large international study suggest. Researchers...

News in brief: Smoking cessation drug unavailable; Zolpidem add-on for OSA treatment; Hospital doctors bullied to discharge patients early

Biologic effective in patients with chronic rhinosinusitis with nasal polyps

“Significant milestone” for inhaled budesonide benefit as early COVID-19 therapy

People with asthma are at less risk of COVID-19, but why? Trial sheds light on how azithromycin reduces asthma exacerbations; Huge spike in RSV in kids sends a public health message

How is long-term azithromycin being used by respiratory physicians in Australia?

News in Brief: Benefits of early selexipag in PAH; Spike in empyema following introduction of 13-valent pneumococcal vaccine

PBS change opens door to dual therapy for more patients with PAH

Macrolide use in kids with wet cough outside guidelines

4 respiratory therapies get PBAC recommendations

Gefapixant gives a taste of what may work for unexplained chronic cough

PBS broadens access to COPD triple therapy and lung cancer immunotherapy

Opioid users to be offered free naloxone nasal spray

Predicting responses to benralizumab

Morphine listed on PBS for chronic breathlessness in palliative care

‘Extreme’ SABA overuse seen with pharmacy OTC inhalers

Industry focus on niche drugs means nothing in pipeline for major diseases

Lung cancer: personalised medicine to be delivered by ‘molecular champions’

PBAC supports low-dose morphine for chronic breathlessness

Antibiotics in respiratory disease an area that needs more attention: AURA

PBS moves for COPD inhalers and new CF treatments

Biologics and respiratory complications: no overt PE risk with TK inhibitors

Digital inhalers to report patient adherence

PBS funding recommended for dual combination therapy in PAH

Benralizumab gets PBS listing

No role for add-on theophylline to prevent COPD exacerbations

New treatments bring new lung toxicities in haematology patients

Deprescribing call for lung cancer patients taking unnecessary medicines

OPTIMIZE trial: long term azithromycin preserves lung function in CF children

Why macrolides should remain a last resort in respiratory patients

PBS tightens up on FDC inhaler use in child asthma

Novel therapies begin to ‘outsmart’ ALK-positive NSCLC

PBS listings approved for novel asthma and IPF treatments

Webinar to address uncontrolled asthma

Cochrane Review highlights lack of evidence for ILD treatment

High dose, low impact: why we need to rethink ICS asthma strategy

Respiratory indications list will make TGA ‘laughing stock of the world’

Respiratory drugs highlighted in PBS costs report

Why macrolides are a must for CAP

Technology set to transform adherence to medications

Oxygen titration important in obese: study

Healthy ROI on cancer drugs for pharma

Study challenges premature baby care

How caffeine helps premature babies breathe easier

GPs not following antibiotics prescribing guidelines

IPF drug pirfenidone now listed on PBS

Ban on sale of homeopathics in shake-up of pharmacy rules

Top gong for respiratory doctor’s decades of service

Have your say on MBS reviews

Call for PBS support for pulmonary hypertension patients

Undignified death for the Cancer Drug Fund

PAH prescribing restrictions out of step with evidence

PAH drug under safety review

Respiratory physicians not following VTE guidelines: survey

Codeine to become prescription only

Lung preservation technique keeps lungs alive for longer

Time to speak up about remuneration for sleep and respiratory diagnostics

Scientists create the ‘ideal’ opioid

Medical marijuana slashes painkiller prescriptions

New drug provides unprecedented cough suppression

TGA approves first NOAC reversal agent

Senate overlooked price of cancer drug: experts

Wasting away: left over cancer drugs costing billions

Macrolides not linked to arrhythmia

Lower oxygen targets up death and disability in pre-term infants

New hep c drugs just days away from PBS listing

You say NOAC and I say DOAC

Cardiac risks of macrolides ‘not negligible’

Stronger warnings issued for champix

OTC codeine gets a reprieve

Restrict access to overprescribed antimicrobials: Atlas

OTC NSAIDs get heart warning

Shared decisions reduce antibiotic prescribing for RTIs

A call to tweet

PBS goes ahead with plans to dispense with common meds

NOAC reversal agents shouldn’t replace common sense

Codeine to become prescription only

Antibiotic dosing strategy doesn’t impact sepsis outcomes

Champix not linked to suicidal behaviour: study

Respiratory drug development not sophisticated enough

Antioxidant slows respiratory decline in Duchenne’s: Lancet